S'abonner

Autoimmune regulator (AIRE) contributes to Dectin-1–induced TNF-⍺ production and complexes with caspase recruitment domain–containing protein 9 (CARD9), spleen tyrosine kinase (Syk), and Dectin-1 - 03/02/12

Doi : 10.1016/j.jaci.2011.08.027 
Luis A. Pedroza, PhD a, b, c, , Vipul Kumar, MS b, , Keri B. Sanborn, PhD b, d, Emily M. Mace, PhD b, Harri Niinikoski, MD, PhD e, Kari Nadeau, MD, PhD f, Dewton de Moraes Vasconcelos, MD, PhD g, Elena Perez, MD, PhD h, Soma Jyonouchi, MD b, Harumi Jyonouchi, MD i, Pinaki P. Banerjee, PhD b, Olli Ruuskanen, MD, PhD e, Antonio Condino-Neto, MD, PhD c, , Jordan S. Orange, MD, PhD b, d, ,
a Center for Investigation in Pediatrics, University of Campinas Medical School, São Paulo, Brazil 
b Department of Pediatrics, Division of Immunology, Children’s Hospital of Philadelphia, Philadelphia, Pa 
c Institute of Biomedical Sciences, Department of Immunology, University of São Paulo, São Paulo, Brazil 
d Immunology Graduate Group, University of Pennsylvania School of Medicine, Philadelphia, Pa 
e Division of Immunology and Allergy, Turku University Hospital, Turku, Finland 
f Division of Immunology and Allergy, Stanford University School of Medicine, Stanford, Calif 
g Laboratory of Dermatology and Immunodeficiency– LIM56, University of São Paulo School of Medicine, São Paulo, Brazil 
h Department of Pediatrics, Division of Allergy and Immunology, University of South Florida School of Medicine, Tampa, Fla 
i Department of Pediatrics, Division of Allergy/Immunology and Infectious Diseases, University of Medicine and Dentistry of New Jersey–New Jersey Medical School, Newark, NJ 

Corresponding author: Jordan S. Orange, MD, PhD, Children’s Hospital of Philadelphia, 3615 Civic Ctr Blvd, ARC 907A, Philadelphia, PA 19104.

Abstract

Background

Autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy (APECED) syndrome is a complex immunologic disease caused by mutation of the autoimmune regulator (AIRE) gene. Autoimmunity in patients with APECED syndrome has been shown to result from deficiency of AIRE function in transcriptional regulation of thymic peripheral tissue antigens, which leads to defective T-cell negative selection. Candidal susceptibility in patients with APECED syndrome is thought to result from aberrant adaptive immunity.

Objective

To determine whether AIRE could function in anticandidal innate immune signaling, we investigated an extrathymic role for AIRE in the immune recognition of β-glucan through the Dectin-1 pathway, which is required for defense against Candida species.

Methods

Innate immune signaling through the Dectin-1 pathway was assessed in both PBMCs from patients with APECED syndrome and a monocytic cell line. Subcellular localization of AIRE was assessed by using confocal microscopy.

Results

PBMCs from patients with APECED syndrome had reduced TNF-⍺ responses after Dectin-1 ligation but in part used a Raf-1–mediated pathway to preserve function. In the THP-1 human monocytic cell line, reducing AIRE expression resulted in significantly decreased TNF-⍺ release after Dectin-1 ligation. AIRE formed a transient complex with the known Dectin-1 pathway components phosphorylated spleen tyrosine kinase and caspase recruitment domain–containing protein 9 after receptor ligation and localized with Dectin-1 at the cell membrane.

Conclusion

AIRE can participate in the Dectin-1 signaling pathway, indicating a novel extrathymic role for AIRE and a defect that likely contributes to fungal susceptibility in patients with APECED syndrome.

Le texte complet de cet article est disponible en PDF.

Key words : Primary immunodeficiency, innate immunity, chronic mucocutaneous candidiasis, monocytes

Abbreviations used : AIRE, APECED, CARD9, CMC, DAPI, FACS, PMA, shRNA, Syk, TLR, WGA


Plan


 Supported by Children’s Hospital of Philadelphia and the Jeffrey Modell Diagnostic Center (J.S.O.), the Vagelos Scholars program in the Molecular Life Sciences of the University of Pennsylvania (V.K.), Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (Brazil; L.A.P.), Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) grant 09/51747-3 for (L.A.P. and A.C.-N.), FAPESP grant 99/07399-7 (D.d.M.V.), and Conselho Nacional de Desenvolvimento Científico e Tecnológico grant 501332/2010-3 (A.C.-N.).
 Disclosure of potential conflict of interest: E. Perez is a consultant for Baxter and CSL Behring; is a chair for the American Academy of Allergy, Asthma & Immunology (AAAAI) Primary Immunodeficiency Committee; is an AAAAI Web reviewer; and is a member of the Clinical Immunology Society Finance Committee. The rest of the authors declare that they have no relevant conflicts of interest.


© 2011  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 129 - N° 2

P. 464 - février 2012 Retour au numéro
Article précédent Article précédent
  • Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial
  • Jonathan M. Spergel, Marc E. Rothenberg, Margaret H. Collins, Glenn T. Furuta, Jonathan E. Markowitz, George Fuchs, Molly A. O’Gorman, Juan Pablo Abonia, James Young, Timothy Henkel, H. Jeffrey Wilkins, Chris A. Liacouras
| Article suivant Article suivant
  • Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita
  • Fabien Touzot, Laetitia Gaillard, Nadia Vasquez, Tangui Le Guen, Yves Bertrand, Jean Bourhis, Thierry Leblanc, Alain Fischer, Jean Soulier, Jean-Pierre de Villartay, Patrick Revy

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.